Business Context and Reporting Period
This Form 8-K Current Report was filed by Whitehorse Finance, Inc. on May 19, 2016. The report addresses a corporate governance issue involving the resignation of a Board of Directors and Audit Committee member, which triggered a compliance failure with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance and corporate governance rather than financial performance.
Material Changes
- Audit Committee Resignation: A member of the Board and Audit Committee resigned, reducing the number of independent directors on the Audit Committee to two.
- Nasdaq Non-Compliance: The Company received notice from Nasdaq stating it failed to comply with Listing Rule 5605, which requires at least three independent directors on the Audit Committee.
Outlook, Risks, and Contingencies
- Cure Period: The Company has been granted a cure period until November 14, 2016, to regain compliance with Nasdaq Rule 5605.
- Remediation Plan: Management is actively identifying an independent director to appoint to the Audit Committee to satisfy the listing requirement before the deadline.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ from forward-looking statements due to various risks and uncertainties.
Investor Verification Checklist
- Confirm the appointment of a new independent director to the Audit Committee before November 14, 2016.
- Monitor subsequent filings for any updates regarding the Company's compliance status with Nasdaq.
- Review the Company's most recent 10-Q or 10-K for financial metrics not included in this 8-K.